NEW YORK (360Dx) – Bio-Techne said after the close of the market on Wednesday that it has completed its acquisition of Exosome Diagnostics for up to $575 million.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.